A supplemental issue published in the Journal of the Pediatric Infectious Diseases Society identified the challenges in controlling childhood TB in 2022 and beyond. ‘What’s New in Childhood Tuberculosis' highlighted areas that can accelerate the prevention, diagnosis, and treatment of a persistent threat to children worldwide.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

The Stop TB Partnership Working Group on New Drugs (WGND)’ Annual Meeting will take place virtually on 3 November 2022.

Three storyboards describe the experiences of people who took TB preventive treatment (TPT): Daud Yamikani of Malawi took a three-month regimen called 3HP after his wife was treated for bone TB, Josephat Asande of Kenya took 3HP when his cousin was staying with him and undergoing treatment for drug-sensitive TB, and Ganesh Acharya of India took TPT for 36 months after a roommate developed TB back in 2009.

On 28 October 2022, the 1/4/6x24 Campaign Coalition hosted a session at the USAID TB Symposium '1/4/6x24 Campaign Call to Action: Kick Starting Momentum Toward the United Nations High-Level Meeting.' Full details about the event are available here.

People with hepatitis C, either treated or untreated, had an increased risk for developing active tuberculosis, according to data published in Clinical Infectious Diseases.

The Call to Action calls on the G20 member countries to ensure continuity of high-quality treatment, care and support services and programming that address the needs of the most affected and vulnerable populations, for a more efficient and effective TB response.

TB deaths increase for a second year in a row and TB incidence rises for the first time in 20 years.

The International Union Against Tuberculosis and Lung Disease (The Union) released its latest quarterly training and education newsletter, sharing the latest news and updates from The Union courses and The Union Conference 2022.

'Disrupted but not defeated' - recognizing TB services providers in areas with armed conflict.